Savara Quarterly Balance Sheet
NASDAQ: SVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Savara financial position
As of Jun 30, 2026, Savara reported total assets of $192.1 million, up 17.3% from a year earlier against total liabilities of $48.5 million. Shareholders' equity stood at $143.7 million, or 74.8% of assets. The company held $41.8 million in cash and equivalents against $30.1 million of debt, a net cash position of $11.7 million.
The current ratio (current assets divided by current liabilities) was 10.13, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.21.
Summary generated from market data by MetaCap's automated system. Methodology
Savara balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 41.80M | 38.79M | 33.18M | 16.28M | 17.44M | 19.56M | 15.13M | 21.43M | 23.86M | 16.79M | 26.59M | 27.69M |
| Short-Term Investments | 131.23M | 163.98M | 202.52M | 108.11M | 129.01M | 152.94M | 181.20M | 198.01M | 97.65M | 126.26M | 135.73M | 140.56M |
| Total Current Assets | 178.32M | 209.26M | 241.62M | 128.20M | 150.99M | 177.44M | 202.13M | 226.40M | 127.69M | 146.19M | 165.95M | 170.10M |
| Property, Plant & Equipment | 641.00K | 130.00K | 100.00K | 85.00K | 119.00K | 138.00K | 165.00K | 206.00K | 236.00K | 248.00K | 270.00K | 277.00K |
| Total Assets | 192.14M | 221.65M | 253.44M | 140.92M | 163.76M | 189.32M | 212.88M | 238.82M | 139.67M | 158.29M | 177.56M | 182.07M |
| Accounts Payable | 7.00M | 4.50M | 5.76M | 4.14M | 4.75M | 5.56M | 4.54M | 4.61M | 3.39M | 2.85M | 3.50M | 3.22M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — |
| Total Current Liabilities | 17.60M | 15.54M | 20.40M | 16.76M | 13.63M | 11.90M | 14.72M | 12.79M | 11.29M | 9.81M | 10.60M | 8.96M |
| Long-Term Debt | 30.11M | 30.07M | 29.91M | 29.78M | 29.65M | 29.52M | 26.62M | 26.55M | 26.48M | 26.42M | 26.35M | 26.28M |
| Total Liabilities | 48.48M | 45.61M | 50.30M | 46.54M | 43.28M | 41.47M | 41.43M | 39.47M | 37.94M | 36.43M | 37.19M | 35.53M |
| Shareholders' Equity | 143.66M | 176.04M | 203.13M | 94.39M | 120.48M | 147.85M | 171.45M | 199.35M | 101.73M | 121.86M | 140.37M | 146.54M |
| Retained Earnings | -685.60M | -645.37M | -608.09M | -575.85M | -546.29M | -515.89M | -489.25M | -460.21M | -435.96M | -413.71M | -393.37M | -377.27M |
| Total Debt | 30.11M | 30.07M | 29.91M | 29.78M | 29.65M | 29.52M | 26.62M | 26.55M | 26.48M | 26.42M | 26.35M | 26.28M |
| Net Cash (Debt) | 142.93M | 172.71M | 205.79M | 94.61M | 116.79M | 142.98M | 169.71M | 192.89M | 95.03M | 116.63M | 135.97M | 141.97M |
| Shares Outstanding | 205.40M | 204.92M | 204.57M | — | 172.85M | 172.70M | 172.42M | 170.84M | 138.20M | 138.18M | 138.14M | 135.34M |
This table shows 12 quarterly periods of Savara's balance sheet, from Q2 2026 back to Q3 2023, across 16 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow SVRA's reporting calendar. What is a balance sheet?